Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells

This publication has 47 references indexed in Scilit:

• PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL
  BMC Bioinformatics, 2012
• The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation
  Leukemia, 2011
• RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
  Oncogene, 2011
• Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
  Cancer Research, 2011
• Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
  Science, 2010
• LL‐37 as a therapeutic target for late stage prostate cancer
  The Prostate, 2010
• Leucine Leucine-37 Uses Formyl Peptide Receptor–Like 1 to Activate Signal Transduction Pathways, Stimulate Oncogenic Gene Expression, and Enhance the Invasiveness of Ovarian Cancer Cells
  Molecular Cancer Research, 2009
• The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
  Proceedings of the National Academy of Sciences, 2009
• Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
  Breast Cancer Research, 2009
• Antimicrobial protein hCAP18/LL‐37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
  International Journal of Cancer, 2005